Frequent absence of tumor suppressor FUS1 protein expression in human bone and soft tissue sarcomas

Anticancer Research

Volumn 31, Issue 1, 2011, Pages 11-21

  Li, Guidong ^a,b   Kawashima, Hiroyuki ^a   Ji, Lin ^c   Ogose, Akira ^a   Ariizumi, Takashi ^a   Umezu, Hajime ^d   Xu, Yongjun ^a   Hotta, Tetsuo ^a   Endo, Naoto ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

FUS1; Growth inhibition; Immunohistochemistry; RT PCR; Sarcoma; Tumor suppressor gene

Indexed keywords

MESSENGER RNA; PROTEIN FUS1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER TISSUE; CELL VIABILITY; FUS1 GENE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMA CELL; SOFT TISSUE SARCOMA; TUMOR SUPPRESSOR GENE;

APOPTOSIS; BLOTTING, WESTERN; BONE NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE THERAPY; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; OSTEOSARCOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SARCOMA; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 79851495475     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59: 225-249, 2009.
2. Goorin AM, Schwartzentruber DJ, Devidas M, Gebhardt MC, Ayala AG, Harris MB, Helman LJ, Grier HE and Link MP: Pediatric Oncology Group: Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol 21: 1574-1580, 2003. (Pubitemid 46594112)
3. Lewis IJ, Nooij MA, Whelan J, Sydes MR, Grimer R, Hogendoorn PC, Memon MA, Weeden S, Uscinska BM, van Glabbeke M, Kirkpatrick A, Hauben EI, Craft AW and Taminiau AH: MRC BO06 and EORTC 80931 collaborators; European Osteosarcoma Intergroup: Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma intergroup. J Natl Cancer Inst 99: 112-118, 2007.
4. Pisters PW: Clinical evaluation and treatment of soft tissue tumors. In: Enzinger and Weiss's Soft Tissue Tumors. 5th edn. Weiss SW and Goldblum JR (eds.). St Louis, Mosby, pp. 15-31, 2001.
5. Lerman MI and Minna JD: The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res 60: 6116-6133, 2000.
6. 1 arrest and growth inhibition of lung cancer cells. Oncogene 20: 6258-6262, 2001. (Pubitemid 32964440)
7. Ji L, Nishizaki M, Gao B, Burbee D, Kondo M, Kamibayashi C, Xu K, Yen N, Atkinson EN, Fang B, Lerman MI, Roth JA and Minna JD: Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res 62: 2715-2720, 2002. (Pubitemid 34462757)
8. Uno F, Sasaki J, Nishizaki M, Carboni G, Xu K, Atkinson EN, Kondo M, Minna JD, Roth JA and Ji L: Myristoylation of the FUS1 protein is required for tumor suppression in human lung cancer cells. Cancer Res 64: 2969-2976, 2004. (Pubitemid 38581390)
9. Prudkin L, Behrens C, Liu DD, Zhou X, Ozburn NC, Bekele BN, Minna JD, Moran C, Roth JA, Ji L and Wistuba II: Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer. Clin Cancer Res 14: 41-47, 2008. (Pubitemid 351377976)
10. Deng WG, Kawashima H, Wu G, Jayachandran G, Xu K, Minna JD, Roth JA and Ji L: Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cells. Cancer Res 67: 709-717, 2007. (Pubitemid 46192211)
11. Deng WG, Wu G, Ueda K, Xu K, Roth JA and Ji L: Enhancement of antitumor activity of cisplatin in human lung cancer cells by tumor suppressor FUS1. Cancer Gene Ther 15: 29-39, 2008. (Pubitemid 350261296)
12. Hotta T, Motoyama T and Watanabe H: Three human osteosarcoma cell lines exhibiting different phenotypic expressions. Acta Pathol Jpn 42: 595-603, 1992.
13. Kawashima H, Ogose A, Gu W, Nishio J, Kudo N, Kondo N, Hotta T, Umezu H, Tohyama T, Nishijima H, Iwasaki H and Endo N: Establishment and characterization of a novel myxofibrosarcoma cell line. Cancer Gent Cytogenet 161: 28-35, 2005. (Pubitemid 41096048)
14. Gu W, Ogose A, Kawashima H, Ito M, Ito T, Matsuba A, Kitahara H, Hotta T, Tokunaga K, Hatano H, Morita T, Urakawa S, Yoshizawa T, Kawashima H, Kuwano R and Endo N: High-level expression of coxsackievirus and adenovirus receptor messenger RNA in osteosarcoma, Ewing's sarcoma, and benign neurogenic tumors among musculoskeletal tumors. Clin Cancer Res 10: 3831-3838, 2004.
15. Ariizumi T, Ogose A, Kawashima H, Hotta T, Umezu H and Endo N: Multinucleation followed by an acytokinetic cell division in myxofibrosarcoma with giant cell proliferation. J Exp Clin Cancer Res 28: 44, 2009.
16. Imaizumi S, Motoyama T, Ogose A, Hotta T and Takahashi HE: Characterization and chemosensitivity of tow human malignant peripheral nerve sheath tumour cell lines derived from a patient with neurofibromatosis type 1. Virchows Arch 433: 435-441, 1998. (Pubitemid 28522032)
17. Sonobe H, Manabe Y, Furihata M, Iwata J, Oka T, Ohtsuki Y, Mizobuchi H, Yamamoto H, Kumano O and Abe S: Establishment and characterization of a new human synovial sarcoma cell line, HS-SY-II. Lab Invest 67: 498-505, 1992.
18. Iwasaki H, Ohjimi Y, Ishiguro M, Isayama T, Kaneko Y, Yoh S, Emoto G and Kikuchi M: Epithelioid sarcoma with an 18q aberration. Cancer Genet Cytogenet 91: 46-52, 1996.
19. Aman P, Ron D, Mandahl N, Fioretos T, Heim S, Arheden K, Willen H, Rydholm A and Mitelman F: Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chromosomes Cancer 5: 278-285, 1992. (Pubitemid 23011197)
20. Fletcher CDM, Unni KK and Mertens F (eds.): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press, 2002.
21. Asaoka K, Tada M, Sawamura Y, Ikeda J and Abe H: Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor. J Neurosurg 92: 1002-1008, 2000. (Pubitemid 30346520)
22. Fernandes-Alnemri T, Litwack G and Alnemri ES: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 269: 30761-30764, 1994. (Pubitemid 24377553)
23. Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G and Murcia JM: Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 273: 33533-33539, 1998. (Pubitemid 29005737)
24. Germain M, Affar EB, D'Amours D, Dixit VM, Salvesen GS and Poirier GG: Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7. J Biol Chem 274: 28379-28384, 1999.
25. Ivanova AV, Ivanov SV, Pascal V, Lumsden JM, Ward JM, Morris N, Tessarolo L, Anderson SK and Lerman MI: Autoimmunity, spontaneous tumourigenesis and IL-15 insufficiency in mice with a targeted disruption of the tumour suppressor gene FUS1. J Pathol 211: 591-601, 2007. (Pubitemid 46502436)
26. Zabarovsky ER, Lerman MI and Minna JD: Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 21: 6915-6935, 2002. (Pubitemid 35221938)
27. Lee DY, Deng Z, Wang CH and Yang BB: MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci USA 104: 20350-20355, 2007.
28. Du L, Schageman JJ, Subauste MC, Saber B, Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD and Pertsemlidis A: miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol Cancer Res 7: 1234-1243, 2009.